Should we offer HRT to ovarian and endometrial cancer survivors? Yes. There is no scientifically valid reason not to do so

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{a898276a7221444d9af2ae97fd682f0b,

title = "Should we offer HRT to ovarian and endometrial cancer survivors? Yes. There is no scientifically valid reason not to do so",

author = "Miller, {David S.}",

year = "2001",

month = sep,

language = "English (US)",

volume = "46",

pages = "31--32+34",

journal = "Emergency Medicine",

issn = "0013-6654",

publisher = "Quadrant Healthcom Inc.",

number = "9",

}

TY - JOUR

T1 - Should we offer HRT to ovarian and endometrial cancer survivors? Yes. There is no scientifically valid reason not to do so

AU - Miller, David S.

PY - 2001/9

Y1 - 2001/9

UR - http://www.scopus.com/inward/record.url?scp=0347080161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347080161&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0347080161

SN - 0013-6654

VL - 46

SP - 31-32+34

JO - Emergency Medicine

JF - Emergency Medicine

IS - 9

ER -